NCT02317172

Brief Summary

Elderly people usually have systemic diseases and take medications that can cause dry mouth. The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in geriatric population with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 11, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 15, 2014

Completed
Last Updated

December 15, 2014

Status Verified

December 1, 2014

Enrollment Period

5 months

First QC Date

December 11, 2014

Last Update Submit

December 11, 2014

Conditions

Keywords

Saliva substituteEdible gelXerostomiaDiabetes MellitusHypertension

Outcome Measures

Primary Outcomes (1)

  • Changes in subjective dry mouth score

    The outcome measure (subjective dry mouth score) will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)

    baseline, 2 weeks and 4 weeks after intervention

Secondary Outcomes (4)

  • Changes in objective dry mouth score

    baseline, 2 weeks and 4 weeks after intervention

  • Changes in salivary Potential of Hydrogen ion (pH)

    baseline, 2 weeks and 4 weeks after intervention

  • Changes in salivary buffering capacity

    baseline, 2 weeks and 4 weeks after intervention

  • Satisfaction of the edible gel-based artificial saliva

    at the first day of trial

Study Arms (1)

Gel-based artificial saliva

EXPERIMENTAL

Continuous oral intake of edible gel-based artificial saliva (30-50 ml/day) for four weeks

Other: Gel-based artificial saliva

Interventions

Gel-based artificial saliva is a novel gel-like, edible moisturizing gel designed to relieve dry mouth.

Also known as: Oral moisturizing jelly
Gel-based artificial saliva

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have systemic diseases such as hypertension or diabetes mellitus and take medications that can cause dry mouth
  • Report symptoms of dry mouth

You may not qualify if:

  • Subjects with uncontrolled systemic diseases
  • Subjects who aspirate upon eating
  • Subjects who smoke
  • Subjects who are allergic to component of the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Health, Ministry of Health

Nonthaburi, 11000, Thailand

Location

Related Publications (1)

  • Dalodom S, Lam-Ubol A, Jeanmaneechotechai S, Takamfoo L, Intachai W, Duangchada K, Hongsachum B, Kanjanatiwat P, Vacharotayangul P, Trachootham D. Influence of oral moisturizing jelly as a saliva substitute for the relief of xerostomia in elderly patients with hypertension and diabetes mellitus. Geriatr Nurs. 2016 Mar-Apr;37(2):101-9. doi: 10.1016/j.gerinurse.2015.10.014. Epub 2015 Nov 26.

MeSH Terms

Conditions

XerostomiaHypertensionDiabetes Mellitus

Condition Hierarchy (Ancestors)

Salivary Gland DiseasesMouth DiseasesStomatognathic DiseasesVascular DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Aroonwan Lam-ubol, DDS, PhD

    Srinakharinwirot University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2014

First Posted

December 15, 2014

Study Start

October 1, 2012

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

December 15, 2014

Record last verified: 2014-12

Locations